These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 22011690)
21. Pharmacokinetic profile of defibrotide in patients with renal impairment. Tocchetti P; Tudone E; Marier JF; Marbury TC; Zomorodi K; Eller M Drug Des Devel Ther; 2016; 10():2631-41. PubMed ID: 27574402 [TBL] [Abstract][Full Text] [Related]
23. Intradialytic administration of daptomycin in end stage renal disease patients on hemodialysis. Salama NN; Segal JH; Churchwell MD; Patel JH; Gao L; Heung M; Mueller BA Clin J Am Soc Nephrol; 2009 Jul; 4(7):1190-4. PubMed ID: 19541812 [TBL] [Abstract][Full Text] [Related]
24. Simplified equations using two concentrations to calculate area under the curve for antimicrobials with concentration-dependent pharmacodynamics: daptomycin as a motivating example. Pai MP; Russo A; Novelli A; Venditti M; Falcone M Antimicrob Agents Chemother; 2014 Jun; 58(6):3162-7. PubMed ID: 24663017 [TBL] [Abstract][Full Text] [Related]
25. Clinical use of ganciclovir during renal failure and continuous hemodialysis. Bastien O; Boulieu R; Bleyzac N; Estanove S Intensive Care Med; 1994; 20(1):47-8. PubMed ID: 8163759 [TBL] [Abstract][Full Text] [Related]
26. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients. Isla A; Gascón AR; Maynar J; Arzuaga A; Toral D; Pedraz JL Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309 [TBL] [Abstract][Full Text] [Related]
28. Elimination of levofloxacin in critically ill patients with renal failure: influence of continuous veno-venous hemofiltration. Bellmann R; Egger P; Gritsch W; Bellmann-Weiler R; Joannidis M; Dunzendorfer S; Wiedermann CJ Int J Clin Pharmacol Ther; 2002 Apr; 40(4):142-9. PubMed ID: 11996208 [TBL] [Abstract][Full Text] [Related]
29. Single-dose pharmacokinetics of daptomycin in young and geriatric volunteers. Dvorchik B; Damphousse D J Clin Pharmacol; 2004 Jun; 44(6):612-20. PubMed ID: 15145969 [TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of polymyxin B in patients on continuous venovenous haemodialysis. Sandri AM; Landersdorfer CB; Jacob J; Boniatti MM; Dalarosa MG; Falci DR; Behle TF; Saitovitch D; Wang J; Forrest A; Nation RL; Zavascki AP; Li J J Antimicrob Chemother; 2013 Mar; 68(3):674-7. PubMed ID: 23179561 [TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and Safety of Omadacycline in Subjects with Impaired Renal Function. Berg JK; Tzanis E; Garrity-Ryan L; Bai S; Chitra S; Manley A; Villano S Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158281 [TBL] [Abstract][Full Text] [Related]
32. Using vancomycin concentrations for dosing daptomycin in a morbidly obese patient with renal insufficiency. Pai MP; Mercier RC; Allen SE Ann Pharmacother; 2006 Mar; 40(3):553-8. PubMed ID: 16507618 [TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of once-daily dosing of ertapenem in critically ill patients with severe sepsis. Brink AJ; Richards GA; Schillack V; Kiem S; Schentag J Int J Antimicrob Agents; 2009 May; 33(5):432-6. PubMed ID: 19091521 [TBL] [Abstract][Full Text] [Related]
34. Phase I trial to investigate the effect of renal impairment on isavuconazole pharmacokinetics. Townsend RW; Akhtar S; Alcorn H; Berg JK; Kowalski DL; Mujais S; Desai AV Eur J Clin Pharmacol; 2017 Jun; 73(6):669-678. PubMed ID: 28271239 [TBL] [Abstract][Full Text] [Related]
35. Influence of morbid obesity on the single-dose pharmacokinetics of daptomycin. Pai MP; Norenberg JP; Anderson T; Goade DW; Rodvold KA; Telepak RA; Mercier RC Antimicrob Agents Chemother; 2007 Aug; 51(8):2741-7. PubMed ID: 17548489 [TBL] [Abstract][Full Text] [Related]
36. Impact of renal replacement modalities on the clearance of piperacillin-tazobactam administered via continuous infusion in critically ill patients. Roger C; Cotta MO; Muller L; Wallis SC; Lipman J; Lefrant JY; Roberts JA Int J Antimicrob Agents; 2017 Aug; 50(2):227-231. PubMed ID: 28689876 [TBL] [Abstract][Full Text] [Related]
37. Steady-state pharmacokinetics and BAL concentration of colistin in critically Ill patients after IV colistin methanesulfonate administration. Imberti R; Cusato M; Villani P; Carnevale L; Iotti GA; Langer M; Regazzi M Chest; 2010 Dec; 138(6):1333-9. PubMed ID: 20558557 [TBL] [Abstract][Full Text] [Related]
38. A Fixed versus Weight-Based Dosing Strategy of Daptomycin May Improve Safety in Obese Adults. Butterfield-Cowper JM; Lodise TP; Pai MP Pharmacotherapy; 2018 Sep; 38(9):981-985. PubMed ID: 29906315 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics and safety of multiple intravenous doses of daptomycin in a Taiwanese adult population. Liang SH; Sheng WH; Huang YT; Wu FL; Chang SC Chemotherapy; 2009; 55(2):91-6. PubMed ID: 19145078 [TBL] [Abstract][Full Text] [Related]
40. Teicoplanin pharmacokinetics and dosage recommendations in chronic hemodialysis patients and in patients undergoing continuous veno-venous hemodialysis. Wolter K; Claus M; Wagner K; Fritschka E Clin Nephrol; 1994 Dec; 42(6):389-97. PubMed ID: 7882603 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]